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NMR spectroscopy is one of the few techniques which has the sensitivity to detect subtle changes to the 
surface chemistry of cells. It has previously been demonstrated that high resolution lH NMR methods can 
distinguish tumour cells with the capacity to metastasise and this information appears to arise from a type 
of proteolipid in or attached to the plasma membrane. Here we report that the *H NMR signal, which we 
have used to identify metastatic ells in rat tumours, is significantly reduced in intensity after cultured cells 
are treated with trypsin/EDTA. The long T2 relaxation value (> 350 ms) observed in metastatic ells is 
absent after enzyme treatment. 2D scalar correlated NMR (COSY) spectra of these treated cells show that 
a cross peak normally associated with malignancy and metastatic disease is markedly reduced. These find- 
ings indicate that the plasma membrane lipid particle which generates the high resolution spectrum is direct- 
ly affected by trypsin/EDTA. Alterations to the cell surface properties were also demonstrated in vivo since 
reduced numbers of metastases were observed in animals injected with enzyme-treated cells. The correlation 
between the absence of a long T, relaxation value and the diminished numbers of metastases in animals 
suggests that the plasma membrane particle is involved in the metastatic process. 
NMR Experimental metastasis TrypsinjEDTA Proteolipid 
1. INTRODUCTION 
The process of metastasis has many steps and 
some of these involve the plasma membrane. Much 
attention has been focussed on cell surface proper- 
ties in malignancy and there is now ample evidence 
that variations in membrane components affect 
metastatic potential [l-4]. Additionally, it has 
been shown that tissue culture procedures alter the 
plasma membrane of cells and affect their 
behaviour when injected into animals. For exam- 
ple, removal of cells from flasks with standard 
trypsin/EDTA treatment results in diminished 
numbers of lung metastases in both B16 melanoma 
[5,6] and murine mammary tumour lines [7]. 
* To whom correspondence should be addressed 
High resolution ‘H NMR spectra from lipids in 
the plasma membrane of cancer cells [8] are an in- 
dication of the biological status of those cells [9]. 
These NMR spectra have been used to monitor 
metastatic potential [lo]. Two-dimensional (2D) 
NMR of whole cells [l l] and chemical analysis of 
highly enriched plasma membranes have identified 
the origin of the high resolution signal as 
predominantly neutral lipids in a particle 
associated with the plasma membrane [12]. This 
particle closely resembles (unpublished) an mRNA 
proteolipid complex produced by malignant cells 
[ 131. In the rat mammary adenocarcinoma 13762 
experimental model, analysis of the NMR spec- 
trum enables us to distinguish cells with metastatic 
potential [lo] by the presence of a long (> 350 ms) 
transverse relaxation parameter, Tz. 
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We report here a study of the N5 clone of the rat 
mammary adenocarcinoma line 13762, where we 
correlate the effect of trypsin/EDTA on in vivo 
metastatic behaviour with its effect in vitro on the 
‘H NMR parameters diagnostic of metastatic 
potential. 
2. MATERIALS AND METHODS 
2.1. Animals 
Female Fisher 344 rats were purchased from 
Charles River Laboratories (Wilmington, MA). 
Rats used in experiments were 8-12 weeks old. 
They were fed normal food and acidified water ad 
libidum. 
end of the experiment by trypan blue exclusion and 
only data from cells with at least 90% viability 
used [9]. 
2.5. NMR spectroscopy 
‘H NMR spectra were recorded and CPMG 
pulse sequences executed as described [12,16]. The 
2D scalar correlated (COSY) pulse sequence used 
for cells has been described in 1111. In our previous 
publications resonances have‘ been referenced to 
the methyl peak at 0.85 ppm. Here we reference to 
an external standard of trimethylsilylpropane- 
sulphonic acid which gives a chemical shift of 
0.91 ppm for the methyl resonance. 
2.2. Cell cultures and cloning procedures 
3. RESULTS 
The origin and properties of the rat mammary 
adenocarcinoma cell line have been described [141. 
The N5 clone was isolated by soft agar plating [ 151. 
Cells, grown in RPMI-1640 medium supplemented 
with 10% foetal calf serum (FCS) at 37”C, were 
maintained in the logarithmic phase of growth 
with a doubling time of 24-26 h. The lightly 
adherent monolayers could be dislodged by simply 
tapping the flask sharply on a padded surface. 
2.3. Experimental metastasis 
Suspension cultures of N5 cells were washed 
twice in 0.9% NaCl, incubated for 10 min with 
0.05% trypsin/0.02% EDTA and suspended for 
10 min in 20 ml RPMI-1640 medium with 10% 
FCS at 37°C. Cells (1 x 10’) were injected into the 
mammary line of 13 rats. Similarly suspension 
cultures of N5 cells were washed twice in 0.9(‘/o 
NaCl and incubated in the absence of enzyme for 
10 min in 20 ml RPMI-1640 medium with 10% 
FCS at 37°C prior to injection into 13 control rats. 
Tumours (-4 cm diameter) were excised 4 weeks 
after implantation. The lungs were removed, 
rinsed in saline and fixed in formalin to be checked 
for lung colonies. Lymph nodes were examined for 
the presence of tumour nodules. 
2.4. Preparation of samples for NMR 
spectroscopy 
Cell samples were prepared for NMR ex- 
periments as described [8] and kept at 37% in the 
NMR tube for 1 h prior to the commencement of 
the experiment. Cell viability was measured at the 
3.1. Animal experiments 
Animals were divided into two groups of 13. 
Treatment of the N5 cells with trypsin/EDTA 
prior to injection in the mammary line of the rats 
resulted in a 38% rate of lymph node metastasis, 
compared to 85% for the untreated control cells. 
No differences were seen in the size of the primary 
tumours in each case and no lung colonies were 
detected. 
3.2. T2 relaxation measurements 
The 400 MHz ‘H NMR spectrum of the N5 cell 
line is shown in fig. 1. The composite resonance at 
1.3 ppm has been assigned to fatty acyl chain 
(-CHz-) resonances of neutral lipids in lipopro- 
tein/proteolipid-like particles in the plasma mem- 
brane of the cells [ 12,161. This resonance can be 
resolved into several components by Lorentzian- 
Gaussian deconvolution techniques [ 171 (fig. I), 
and the Tz values of these component peaks 
measured. The long TZ value (>350 ms) of the 
peak at 1.33 ppm has previously been shown to 
correlate with metastatic behaviour in the rat 
mammary adenocarcinoma experimental model 
[lo]. The measured T2 values for all resolved peaks 
are decreased after enzyme treatment, but the peak 
at 1.33 ppm shows the most dramatic change 
(table 1). In the untreated N5 cells this peak has a 
T2 of 794 ms which after exposure to trypsin/ 
EDTA decreases to 176 ms. Comparison of fig.lA 
and B reveals that the intensity of this peak is 
greatly diminished by enzyme treatment, and it is 
this remaining signal that has the TZ of 176 ms. 
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Fig. 1. 400 MHz ‘H NMR spectra of a suspension of N5 
cells (1 x 1O8) in phosphate-buffered saline in D20. Data 
were obtained at 37°C with the sample spinning and with 
suppression of residual HOD signals by gated 
irradiation. The resonances under the composite (-CHz-) 
peak were resolved by application of the Lorentzian- 
Gaussian enhancement echnique [ 171. The resolution 
enhanced spectra are plotted over the methylene region 
(1.2-1.4 ppm), on an expanded scale. (A) Untreated 
cells. (B) Cells treated with 0.05% trypsin and 0.02% 
EDTA. 
3.3. 20 COSY experiments 
A contour plot of the 400 MHz 2D COSY spec- 
trum of N5 cells is shown in fig.2. Many of the 
cross peaks in the 2D spectra of cancer cells arise 
from lipids, as shown by the lipid connectivities 
designated A-G in the triglyceride structure 
[ 11,12,16]. Other cross peaks arise from soluble 
cytoplasmic components and are indicated by ar- 
rows [12]. 
Cross peak Y is of particular interest. It connects 
resonances at 1.3 and 4.2 ppm and appears in the 
spectra of all malignant and metastatic cells and 
tumours studied thus far. The connectivity is not 
consistent with protons in an acyl chain and re- 
mains to be assigned. It coincides with the peaks at 
1.35 and 1.33 ppm observed in the resolution 
enhanced spectrum. Fig.2A shows a vertical slice 
through the COSY contour plot at 4.2 ppm, and 
cross peak Y (at 1.3 ppm) is clearly observed in the 
untreated N5 cells. However, after treatment with 
trypsin or EDTA the intensity of this peak is re- 
duced by approx. 60% (fig.ZB). 
4. DISCUSSION 
We have been able to diminish both metastatic 
ability (as deduced by in vivo assays), and the 
signal which gives the long TZ value by trypsin/ 
EDTA treatment. These data suggest that the 
NMR signal giving rise to the long TZ value arises 
from the outside of the cell, and that the particle 
we are observing is involved in the metastatic 
process. 
Table 1 
Transverse relaxation parameter (Tz) for resonances 
under the methylene in cell line N5 before and after 
treatment with trypsin/EDTA 
Chemical shift TZ (ms) 
(ppm) 
Control Enzyme treated 
1.30 188 f 19 137 + 18 
1.31 219 + 12 151 _t 9 
1.33 794 * 58 176 + 12 
1.35 241& 6 123 _+ 17 
Spectra were resolution enhanced by the Lorentzian- 
Gaussian method [17]. Results are expressed as the 
mean * SE of 2 experiments 
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Fig.2. 400 MHz ‘H NMR 2D COSY spectrum of a 
suspension of NS cells (1 x 108) in phosphate-buffered 
saline in DzO. Data were obtained at 37°C with the 
sample spinning and with suppression of residual HOD 
signals by gated irradiation. Sine-bell and Gaussian 
(LB = - 30, GB = 0.25) window functions were applied 
in the tl and t2 domains, respectively. Cross peaks are 
assigned as described [11,12], with reference to the 
labelled structure. A vertical slice through the COSY 
contour plot at 4.2 ppm yields all the protons coupled to 
that peak. Cross peaks G and G’ are the vicinal 
methylene-methine a d geminal couplings, respectively, 
in the glycerol portion of triglyceride [11,12,16]. Cross 
peak Y is not yet unequivocally assigned. (A) Untreated 
cells. (B) Cells treated with 0.05% trypsin and 0.02% 
EDTA. 
Cross peak Y in the 2D spectrum is decreased 
under these experimental conditions and, although 
the nature of the chemical species generating this 
NMR signal is not yet identified, these data suggest 
that it is an integral part of the proteolipid-like 
particle we detect in malignant cells using NMR 
spectroscopy. The significant decrease in the inten- 
sity of the resonance at 1.33 ppm after tryp- 
sin/EDTA treatment (fig.1) is consistent with the 
reduction of cross peak Y in the 2D spectrum 
(fig.2). Collectively these data suggest that an 
overlying resonance has been removed by the tryp- 
sin/EDTA treatment and the remaining short TZ of 
176 ms is from the underlying lipid resonance 
which gives rise to cross peak B (fig.2). 
The involvement of plasma membrane vesicles 
in the transfer of metastatic potential from one cell 
to another was first described by Poste and 
Nicolson [l]. It is possible that proteolipid com- 
plexes [ 131 were amongst he vesicles transferred in 
these experiments. 
Isolation of proteolipids produced by malignant 
cells in vitro may help to identify the functional 
molecules and establish their role in the metastatic 
process. 
ACKNOWLEDGEMENT 
We would like to thank Professor M.H.N. Tat- 
tersall for helpful discussions. 
125 
Volume 202, number 1 FEBS LETTERS June 1986 
REFERENCES 
(11 Poste, G. and Nicolson, G.L. (1980) Proc. Natl. 
Acad. Sci. USA 17, 399-403. 
[2] Fidler, I.J. (1985) Cancer Res. 45, 4714-4726. 
[3] Speck, P.A. and Nicolson, G.L. (1984) 
Transplantation Proceedings XVI, 355-360. 
[4] Nicolson, G.L. (1984) Cancer Metastasis Rev. 3, 
25-42. 
[5] Greig, R., Catabiano, L., Feild, J., Reid, R. and 
Poste, G. (1985) Int. J. Cancer 35, 367-375. 
[6] Sargent, N.S.E., Price, J.E. and Tarin, D. (1983) 
Br. J. Cancer 48, 569-577. 
[7] Fidler, I.J. (1978) Methods Cancer Res. XV, 
399-439. 
[S] Mountford, C.E., Grossman, G., Reid, G. and 
Fox, R.M. (1982) Cancer Res. 42, 2270-2276. 
[9] Mountford, C.E., Holmes, K.T. and Smith, I.C.P. 
(1986) NMR in Cancer: Progress in Clinical 
Biochemistry and Medicine ~01.3, pp.73-112, 
Springer, Heidelberg. 
(lo] Mountford, C.E., Wright, L.C., Holmes, K.T., 
Mackinnon, W.B., Gregory, P. and Fox, R.M. 
[ 131 Wieczorek, A. J., Rhyner, G. and Block, L.H. 
(1984) Science 226, 1415-1418. 
[ 111 Cross, K.J., Holmes, K.T., Mountford, C.E. and 
Wright, P.E. (1984) Biochemistry 23, 5895-5897. 
(1985) Proc. Natl. Acad. Sci. USA 82, 3455-3459. 
[12] May, G.L., Wright, L.C., Holmes, K.T., Williams, 
[14] Ramshaw, LA., Carlsen, S.T., Hoon, D. and 
P.G., Smith, I.C.P., Wright, P.E., Fox, R.M. and 
Mountford, C.E. (1986) J. Biol. Chem. 261, 
3048-3053. 
Warrington, R.C. (1982) Int. J. Cancer 30, 601. 
[15] Reid, L.C.M. (1979) Methods Enzymol. 58, 
152-164. 
[16] Williams, P.G., Helmer, M., Wright, L.C., Dyne, 
M., Fox, R.M., Holmes, K.T., May, G.L. and 
Mountford, C.E. (1985) FEBS Lett. 192, 159-164. 
[ 171 Mountford, C.E., Mackinnon, W.B., Bloom, M., 
Burnell, E.E. and Smith, I.C.P. (1984) J. Biochem. 
Biophys. Methods 9, 323-330. 
126 
